These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1091 related items for PubMed ID: 20618365

  • 1. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A, Mukhopadhyay T, Ramani VS, Perkins K, Snee AJ, Jelley F, Wong H, Lee CD.
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [Abstract] [Full Text] [Related]

  • 2. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience.
    Sun Myint A, Lee CD, Snee AJ, Perkins K, Jelley FE, Wong H.
    Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396
    [Abstract] [Full Text] [Related]

  • 3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 4. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1098-105. PubMed ID: 15519780
    [Abstract] [Full Text] [Related]

  • 5. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer.
    Chao M, Gibbs P, Tjandra J, Cullinan M, McLaughlin S, Faragher I, Skinner I, Jones I.
    ANZ J Surg; 2005 May 15; 75(5):286-91. PubMed ID: 15932438
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ, Shakespeare TP, Tan LK, Goh BC, Cooper JS.
    Head Neck; 2004 May 15; 26(5):389-95. PubMed ID: 15122654
    [Abstract] [Full Text] [Related]

  • 7. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG.
    Ann Surg; 2008 Aug 15; 248(2):243-51. PubMed ID: 18650634
    [Abstract] [Full Text] [Related]

  • 8. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
    Klenova A, Parvanova V, Georgiev R, Gesheva N.
    J BUON; 2006 Aug 15; 11(2):161-6. PubMed ID: 17318965
    [Abstract] [Full Text] [Related]

  • 9. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
    Klenova A, Georgiev R, Kurtev P, Kurteva G.
    J BUON; 2007 Aug 15; 12(2):227-32. PubMed ID: 17600877
    [Abstract] [Full Text] [Related]

  • 10. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):463-71. PubMed ID: 16168838
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
    Wu B, Qiu HZ, Xiao Y, Lin GL, Niu BZ, Zhang FQ, Hu K.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar 01; 11(2):124-7. PubMed ID: 18344077
    [Abstract] [Full Text] [Related]

  • 12. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M.
    Ann Surg Oncol; 2008 Oct 01; 15(10):2661-7. PubMed ID: 18389322
    [Abstract] [Full Text] [Related]

  • 13. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW, Jacobsen A, Qvortrup C, Hansen F, Bisgaard C, Baatrup G, Rasmussen P, Pfeiffer P.
    Acta Oncol; 2008 Oct 01; 47(3):428-33. PubMed ID: 18348002
    [Abstract] [Full Text] [Related]

  • 14. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J, Vera R, Balén E, Gómez M, Arias F, Lera JM, Herrera J, Zazpe C.
    Colorectal Dis; 2008 Jul 01; 10(6):563-8. PubMed ID: 18070184
    [Abstract] [Full Text] [Related]

  • 15. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):665-77. PubMed ID: 15708244
    [Abstract] [Full Text] [Related]

  • 16. [Exploration on neoadjuvant chemoradiation in the treatment for locally advanced low rectal cancer].
    Yu BM, Zhang M, Peng LH, Bian GW, Wu WQ, Chen LW, Fu J, Fei CS.
    Zhonghua Wai Ke Za Zhi; 2009 Oct 15; 47(20):1540-3. PubMed ID: 20092741
    [Abstract] [Full Text] [Related]

  • 17. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH, Lee KC, Choi JH, Oh JH, Baek JH, Park SH, Shin DB.
    Jpn J Clin Oncol; 2008 Feb 15; 38(2):112-21. PubMed ID: 18263881
    [Abstract] [Full Text] [Related]

  • 18. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
    Vestermark LW, Jensen HA, Pfeiffer P.
    Acta Oncol; 2012 Mar 15; 51(3):311-7. PubMed ID: 22248062
    [Abstract] [Full Text] [Related]

  • 19. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.
    Cancer Radiother; 2004 Jun 15; 8(3):168-77. PubMed ID: 15217584
    [Abstract] [Full Text] [Related]

  • 20. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
    Mawdsley S, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, Ashford R, Harrison RA, Osborne M, Livingstone JI, MacDonald P, Mitchell IC, Meyrick-Thomas J, Northover JM, Windsor A, Novell R, Wallace M.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):745-52. PubMed ID: 16199310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.